Lv5
878 积分 2023-09-20 加入
Cellular neighborhoods in cancer
13天前
已完结
Prime editing: redefining precision genome editing
16天前
已完结
Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis
28天前
已完结
The Curated Cancer Cell Atlas provides a comprehensive characterization of tumors at single-cell resolution
30天前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
1个月前
已完结
A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
4个月前
已完结
1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma (la/mUC): RC48G001 cohort C
5个月前
已关闭
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
5个月前
已完结
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials
5个月前
已完结
Restoring function in exhausted CD8 T cells during chronic viral infection
5个月前
已完结
皖公网安备34019202002308
